Practical, role-targeted guides on building and choosing electronic signatures that survive an FDA or EMA, written for the people who own the risk.
The complete guide to Part 11 & Annex 11 e-signatures — what regulators require and how to evaluate a system built for trials.
A signature failure can cost a milestone, a partnership, or the trial. Why this is a CEO problem, not just a QA one.
The bottleneck was never signing — it was chasing, version confusion, and reconciliation. Reduce the tax, keep the controls.
A control-by-control checklist to confirm your e-signatures are defensible — before an inspector tests them for you.
One trial is a workflow problem; a portfolio is a governance problem. Standardize signatures without slowing sites.
A signed file in an inbox isn't a record — it's a reconciliation task waiting to become a finding. Keep signatures tied to the record.
Book a discovery call and we’ll walk your signing workflow against the Part 11 and Annex 11 controls that matter.
Book a Discovery Call